Figure 2.
SARS-CoV-2 evades TLR recognition and thereby suppressing IFN-1 production.
Notes: Reproduced from Rowaiye, A.; Okpalefe, O.; Onuh, O.; Ogidigo, J.; Oladipo, O.; Ogu, A.; Oli, A.; Olofinase, S.; Onyekwere, O. Preparing for the Storm: Mitigating the Effect of SARS-CoV-2 Induced Hypercytokinemia. Preprints 2020, 2020110604. Creative Commons license and disclaimer available from: http://creativecommons.org/licenses/by/4.0/legalcode.